Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2336030
Max Phase: Preclinical
Molecular Formula: C20H20N4O
Molecular Weight: 332.41
Molecule Type: Small molecule
Associated Items:
ID: ALA2336030
Max Phase: Preclinical
Molecular Formula: C20H20N4O
Molecular Weight: 332.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)NCC(C)C)cc1C#Cc1cnc2ccnn2c1
Standard InChI: InChI=1S/C20H20N4O/c1-14(2)11-22-20(25)18-6-4-15(3)17(10-18)7-5-16-12-21-19-8-9-23-24(19)13-16/h4,6,8-10,12-14H,11H2,1-3H3,(H,22,25)
Standard InChI Key: CUXDTXRODFHEHG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 332.41 | Molecular Weight (Monoisotopic): 332.1637 | AlogP: 2.82 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.35 | CX LogP: 3.61 | CX LogD: 3.61 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.75 | Np Likeness Score: -1.51 |
1. Gao M, Duan L, Luo J, Zhang L, Lu X, Zhang Y, Zhang Z, Tu Z, Xu Y, Ren X, Ding K, Ding K.. (2013) Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors., 56 (8): [PMID:23521020] [10.1021/jm301824k] |
Source(1):